Pharmaceutical Online News
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. 
Subscribe to this data using MyMedWorm.
Subscribe to this data using GoogleReader.
Subscribe to this data using Bloglines.
Subscribe to this data using MyYahoo.
Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.
This page shows you the latest items in this publication.
1567 records returned
SinoFresh Nasal Spray Achieves Positive Results Against H1N1 (Swine Flu) Virus In Initial Pilot Animal Study
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
SinoFresh Healthcare Products, Inc. announced today the successful results of its initial pilot animal study testing the efficacy of the SinoFresh Nasal Spray product when used on animals infected with the H1N1 ("swine flu") virus. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - November 19, 2009 Category: Pharmaceuticals Source Type: news
Scancell Selects PharmaNet Development Group For SCIB1 Clinical TrialEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Scancell Holdings Plc, (PLUS:SCLP), the parent company of Scancell Limited ('Scancell'), the developer of innovative therapeutic cancer vaccines, is pleased to announce that it expects to commence its Phase I/II clinical trial with SCIB in the first half of 2010. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - November 19, 2009 Category: Pharmaceuticals Source Type: news
PPD To Acquire BioDuroEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
PPD, Inc. (Nasdaq: PPDI) today announced it has signed an agreement to acquire BioDuro LLC, a drug discovery outsourcing company that provides a broad range of integrated services to biopharmaceutical companies. The acquisition will expand PPD's drug development capabilities in China. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - November 19, 2009 Category: Pharmaceuticals Source Type: news
High Volume Microplate For Sensitive Photometric AssaysEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
With a well volume of 3.1ml the Krystal 24 from Porvair Science Ltd. is the microplate of choice for screening applications that require high sensitivity combined with photometric accuracy and repeatability. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - November 19, 2009 Category: Pharmaceuticals Source Type: news
Mysteries Solved With Rheology - Fifth eLearning Course From Anton PaarEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The most recent addition to Anton Paar's award-winning series of interactive eLearning courses has arrived: 'Basics of Rheometry I Oscillation' follows the four previous courses about density measurement, CO2 content determination, viscometry and rotational rheometry. The CD provides a basic introduction to the science of rheological oscillatory testing. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - November 19, 2009 Category: Pharmaceuticals Source Type: news
Accelerating Safe Concentration Of Accelerated Solvent Extraction SamplesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Genevac has announced the Puck - a new sampling accessory that extends the sampling versatility of its Rocket™ Evaporator to simultaneously accommodate up to eighteen 60ml Accelerated Solvent Extractor (ASE®) tubes. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - November 19, 2009 Category: Pharmaceuticals Source Type: news
Patheon, Inc. Announces The Appointment Of Francisco R. Negron As Vice President And General Manager Of Its Puerto Rico OperationsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Patheon, Inc., a global provider of drug development and manufacturing services to the international pharmaceutical industry announced today that it has named Francisco R. Negron as Vice President and general manager of its Puerto Rico operations. Mr. Negron will be based at the company's Manati site. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - November 19, 2009 Category: Pharmaceuticals Source Type: news
Kinexus Expert System Rheometry Promotes Formulation SuccessEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Manufacturers and materials professionals can now access an online article that describes the efficient application of performance-controlling design rules through the use of expert system rheometry. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - November 19, 2009 Category: Pharmaceuticals Source Type: news
Versatile Aspiration System For Safe Vacuum Disposal Of LiquidsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
INTEGRA Biosciences has extended its VACUSAFE aspiration system with new models for laboratories wishing to utilise an existing supply of vacuum while benefiting from many of the advantages of the internationally popular product. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - November 19, 2009 Category: Pharmaceuticals Source Type: news
Personalized Medicine Drives Multiple Markets, Finds Frost & SullivanEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
With the launch of several companion diagnostics over the past year, we have officially entered the personalized medicine era. These diagnostics and follow-on therapeutics utilize molecular analysis technologies to diagnose and manage a patient's disease or predisposition towards a disease. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - November 18, 2009 Category: Pharmaceuticals Source Type: news
Results From Two Phase II Trials Add To Understanding Of Ticagrelor (BRILINTA™) And How It Works In The BodyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
AstraZeneca (NYSE: AZN) today announced the results of the phase II studies, ONSET/OFFSET and RESPOND for ticagrelor (BRILINTA(TM)) at the annual American Heart Association (AHA) Scientific Sessions in Orlando, FL,(1,2) with ONSET/OFFSET study results being simultaneously published in the medical journal Circulation.(3) (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - November 18, 2009 Category: Pharmaceuticals Source Type: news
BioTek Announces Epoch Contest WinnerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
BioTek Instruments, Inc., announces the winner of the "Win a Free Epoch Multi-Volume Spectrophotometer System" contest. The contest, which ran from August 24 through November 12, marked the launch of BioTek's Epoch™ Multi-Volume Spectrophotometer System. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - November 18, 2009 Category: Pharmaceuticals Source Type: news
Multisorb Technologies APA-9000 Series Canister DispenserEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The APA 9000 Canister Dispenser is a high-speed automatic dispenser capable of dispensing rates up to 325 canisters per minute. The APA-9000 can be used to dispense SorbiCap, Multiform CSF or StabilOx canisters in a variety of lines including: bottling, VFFS, flow wrapper, thermoform and pouching machinery. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - November 18, 2009 Category: Pharmaceuticals Source Type: news
SP Industries Announces Flexible Immersion CoolerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The FTS FlexiCool® Immersion Cooler from SP Industries Inc. provides reliable, rapid cooling capability, down to -100ºC, just where you need it. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - November 18, 2009 Category: Pharmaceuticals Source Type: news
Federal Equipment Announces Used Equipment List From Solid Dose Pharmaceutical Plant LiquidationEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
For more than 50 years, Federal Equipment Company has been a trusted name in the used chemical processing equipment industry. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - November 18, 2009 Category: Pharmaceuticals Source Type: news
BioTek Instruments Named Lake Champlain Regional Chamber Of Commerce Business Of The YearEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The Lake Champlain Regional Chamber of Commerce named BioTek Instruments, Inc., as Business of the Year at their 99th annual awards ceremony on Tuesday, November 11, 2009. The One Community, One Commitment, One Vision event drew more than 650 people from Lake Champlain area businesses. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - November 18, 2009 Category: Pharmaceuticals Source Type: news
ConsumerLab.com Finds Many Probiotics Don't Deliver Listed IngredientsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Many probiotic supplements do not contain the number of viable organisms listed on their labels according to a new report from ConsumerLab.com. The testing organization found that at the time a probiotic is purchased it may contain as little as 10% to 58% of the amount listed on its label. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - November 17, 2009 Category: Pharmaceuticals Source Type: news
Poniard Pharmaceuticals Announces Updated Positive Clinical Data From Phase 2 Trial Of Picoplatin In Colorectal Cancer And New Phase 1 Cardiac Safety Trial ResultsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Poniard Pharmaceuticals, Inc. (Nasdaq: PARD ) today announced updated clinical data from its randomized, controlled Phase 2 trial of picoplatin in patients with metastatic colorectal cancer (CRC). (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - November 17, 2009 Category: Pharmaceuticals Source Type: news
Higher Dose of Merck's COZAAR (Losartan Potassium Tablets) Significantly Reduced Deaths and Hospitalizations Due to Heart Failure In Investigational StudyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
In an investigational study, Merck's medicine COZAAR (losartan potassium tablets) 150 mg, administered once daily, significantly reduced the risk of all-cause death or hospitalization due to heart failure compared to a lower 50 mg once daily dose of COZAAR. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - November 17, 2009 Category: Pharmaceuticals Source Type: news
C.W. Brabender Instruments, Inc. Introduces The NEW Mini-Compounder 12mm Miniature Twin Screw Extruder For The Plastics And Pharmaceutical IndustriesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
C.W. Brabender Instruments, Inc. introduces the Brabender Mini-Compounder TSE 12/36, a miniature co-rotating twin screw extruder with application to the chemical as well as the pharmaceutical industry for development of new products. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - November 17, 2009 Category: Pharmaceuticals Source Type: news
Continuous Roll Microplate Heat SealerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The TriSeal Pro from Porvair Sciences Ltd. is a new budget-priced continuous roll microplate heat sealer optimised for medium to high throughput plate sealing applications. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - November 17, 2009 Category: Pharmaceuticals Source Type: news
Open House For Tampa Bay Packaging CompaniesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
New England Machinery, Inc. (NEM) announced that it will be one of the 10 packaging companies hosting an Open House for interested customers the week of February 22 through 26, 2010. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - November 17, 2009 Category: Pharmaceuticals Source Type: news
NOVAVAX Completes First Stage Of Enrollment In Pivotal H1N1 Influenza Vaccine Study In The Country Of MexicoEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Novavax, Inc. (Nasdaq: NVAX
) announced today that enrollment has been completed in the first stage of a two-stage clinical study of its novel 2009 H1N1 virus-like-particle (VLP) pandemic influenza unadjuvanted vaccine in the country of Mexico. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - November 16, 2009 Category: Pharmaceuticals Source Type: news
Hollis-Eden Presents New Interim Data From Prostate Cancer Phase I/II Clinical Studies Of Apoptone (HE3235) At AACR Molecular Targets And Cancer Therapeutics ConferenceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Hollis-Eden Pharmaceuticals, Inc. (Nasdaq: HEPH
), today reported preliminary results of its ongoing Phase I/II clinical trial with Apoptone® (HE3235) for hormone-resistant prostate cancer (also called castrate-resistant prostate cancer or CRPC). (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - November 16, 2009 Category: Pharmaceuticals Source Type: news
ThromboGenics And BioInvent Complete Phase I Patient Trial Of Anti-PlGF Cancer Therapeutic TB-403 In Patients With Advanced Solid TumoursEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ThromboGenics NV (Euronext Brussels: THR) and BioInvent International AB (OMXS: BINV) today announced positive results from a Phase I trial of their novel anti-cancer monoclonal antibody TB-403 in patients with advanced solid tumours. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - November 16, 2009 Category: Pharmaceuticals Source Type: news
Biomodels Scientists Report Development Of A Novel Model For Cancer Treatment-Related FatigueEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Scientists at Biomodels
have successfully developed the first model that accurately duplicates human cancer treatment-related fatigue
(CTRF). (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - November 16, 2009 Category: Pharmaceuticals Source Type: news
GSK And Nabi Announce Agreement For NicVAX, A Vaccine For Nicotine AddictionEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
GlaxoSmithKline Biologicals SA (GSK) and Nabi Biopharmaceuticals (Nabi) recently announcedan exclusive worldwide option and licensing agreement for a nicotine conjugate candidate vaccine (NicVAX), an investigational vaccine for the treatment of nicotine addiction and the prevention of smoking relapse, as well as for the development of a second generation nicotine vaccine. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - November 16, 2009 Category: Pharmaceuticals Source Type: news
Abbott Announces Positive Three-Year Data On Its Fully Bioabsorbable Stent Technology, Initiates Large-Scale International TrialEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Abbott (NYSE: ABT) today announced three-year data from the first 30 patients in the first phase of the ABSORB clinical trial, demonstrating that its fully bioabsorbable drug eluting coronary stent successfully treated coronary artery disease and was absorbed into the walls of treated arteries. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - November 16, 2009 Category: Pharmaceuticals Source Type: news
FDA Approves Additional Vaccine For 2009 H1N1 Influenza VirusEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The U.S. Food and Drug Administration announced that it has approved a fifth vaccine for protection against the 2009 H1N1 influenza virus. The vaccine is manufactured by ID Biomedical Corp. of Quebec, Canada, owned by GlaxoSmithKline PLC. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - November 16, 2009 Category: Pharmaceuticals Source Type: news
Merck Expresses Confidence In The Efficacy And Safety Profiles Of ZETIA (ezetimibe) And VYTORIN (ezetimibe/simvastatin) As Effective Medicines For Managing Elevated CholesterolEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
At the American Heart Association meeting recently, Merck & Co., Inc. said it is confident in the safety and efficacy profiles of ZETIA (ezetimibe) and VYTORIN (ezetimibe/simvastatin), and issued the following comment in response to misinterpretation of results from a small 200-patient imaging study called ARBITER 6. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - November 15, 2009 Category: Pharmaceuticals Source Type: news
Abbott Statement On ARBITER 6 - HALTS Results And Abbott's Niaspan (Niacin Extended-Release)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Results from the investigator-initiated ARBITER 6 - HALTS study showed patients at high cardiovascular risk had significant regression of atherosclerosis after 8 and 14 months of therapy with Abbott's Niaspan® (niacin extended-release tablets) plus a statin, the study's primary endpoint. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - November 15, 2009 Category: Pharmaceuticals Source Type: news
Deflection Monitor From Eriez® Protects Vibratory Feeders And Conveyors By Detecting Overflow Material And Damaged ComponentsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The Deflection Monitor from Eriez ® intelligently tracks the operation of vibratory feeders and conveyors to prevent any damage during operation. The unit can detect abnormal amounts of material on vibratory trays or when some feeder components are failing. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - November 13, 2009 Category: Pharmaceuticals Source Type: news
Collaborative Work Employs Complementary Particle Characterization Tools For Inhaler DevelopmentEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
At Drug Delivery to the Lungs 20 (DDL 20), which takes place from 9 to 11 December 2009, in Edinburgh, Scotland, specialists from Malvern Instruments will present the results of work undertaken in collaboration with the Helsinki University of Technology. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - November 13, 2009 Category: Pharmaceuticals Source Type: news
TET Systems And Novo Nordisk Sign License AgreementEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
TET Systems Holding GmbH & Co. KG ("TET Systems"), a worldwide leader in controlled gene expression, today announced that TET Systems and Novo Nordisk A/S have signed a license agreement allowing the Hagedorn Research Institute (HRI), a research institute within Novo Nordisk A/S, the use of the Tet Technology for its internal research activities. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - November 13, 2009 Category: Pharmaceuticals Source Type: news
Genzyme Issues Letters To U.S. Healthcare ProvidersEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Genzyme Corp. announced recently that it has issued letters to U.S. healthcare providers regarding its enzyme replacement products Cerezyme (imiglucerase for injection), Fabrazyme (agalsidase beta), Myozyme (alglucosidase alfa), Aldurazyme (laronidase), as well as Thyrogen (thyrotropin alfa for injection), filled at its Allston Landing manufacturing facility. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - November 13, 2009 Category: Pharmaceuticals Source Type: news
GoIndustry DoveBid Has Been Awarded 'Corporate Supplier Excellence Award' By Procter & GambleEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The Procter & Gamble Company (NYSE: PG) hosted its annual supplier awards event on Tuesday 3rd November recognizing the company's top performing suppliers. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - November 12, 2009 Category: Pharmaceuticals Source Type: news
Abbott To Acquire Novel Investigational Biologic To Treat Chronic PainEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Abbott (NYSE: ABT) announced today a definitive agreement to acquire the global rights to PanGenetics BV's PG110 fully humanized antibody to Nerve Growth Factor (NGF), expanding the company's pain care portfolio and leveraging its expertise in biologics. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - November 12, 2009 Category: Pharmaceuticals Source Type: news
Ross Stocks Dual Shaft MixersEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Charles Ross and Son Company today announced the in-stock availability several sizes of its Dual Shaft Change Can Mixers. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - November 12, 2009 Category: Pharmaceuticals Source Type: news
INTERPHEX Aligns Management Team To Enhance Customer Value And ExperienceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
INTERPHEX, North America's largest event for the biopharmaceutical manufacturing industry, has aligned its management team to focus its efforts on the customer experience by strengthening key alliances to identify and cultivate new visitor growth. These efforts are being undertaken to embrace the changing needs of the Pharma and biotech marketplace while delivering customer value and engagement thus fortifying the INTERPHEX brand. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - November 12, 2009 Category: Pharmaceuticals Source Type: news
Endo Pharmaceuticals And LecTec Settle Patent DisputeEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Endo Pharmaceuticals (Nasdaq: ENDP ) announced today that it has reached a settlement with LecTec Corporation on outstanding patent litigation related to LecTec's U.S. Patent Nos. 5,536,263 and 5,741,510. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - November 12, 2009 Category: Pharmaceuticals Source Type: news
Exploring Powder Dispersion For Inhaled Drug ApplicationsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Dr Paul Kippax, product manager for diffraction systems at Malvern Instruments, is one of a group of powder dispersion and characterization experts who will speak in Leeds, UK, on 8 December 2009 at a meeting on 'Dispersion and Characterization of Dry Cohesive Powders for Inhalation and Particle Sizing'. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - November 11, 2009 Category: Pharmaceuticals Source Type: news
Right First Time: Pioneering New Methods Of Drug ManufactureEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Engineers at the University of Leeds have developed a simple technology which can be used in existing chemical reactors to ensure "right first time" drug crystal formation. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - November 11, 2009 Category: Pharmaceuticals Source Type: news
Academy Launches Study On The Use Of Animals Containing Human MaterialEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The Academy of Medical Sciences has launched a new study to examine the use of
animals containing human material in scientific research. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - November 11, 2009 Category: Pharmaceuticals Source Type: news
IACC Includes Vaccine Research Objective In Strategic Plan For Autism ResearchEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Autism Speaks is encouraged by yesterday's decision of the Interagency Autism Coordinating Committee (IACC) to include vaccine research studies in the objectives of the updated Strategic Plan for Autism Research. The new language, approved unanimously, calls for studies to determine if there are sub-populations that are more susceptible to environmental exposures such as immune challenges related to naturally occurring infections, vaccines or underlying immune problems. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - November 11, 2009 Category: Pharmaceuticals Source Type: news
Westaim Announces Amalgamation Agreement With NUCRYST PharmaceuticalsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The Westaim Corporation (TSX: WED) today announced the execution of an amalgamation agreement with NUCRYST Pharmaceuticals Corp. (NASDAQ: NCST; TSX: NCS). Under the agreement, NUCRYST will amalgamate with a newly-formed, wholly-owned subsidiary of Westaim (the "Amalgamation"). (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - November 11, 2009 Category: Pharmaceuticals Source Type: news
Sanofi-aventis And Regeneron Expand Strategic Antibody CollaborationEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) announced today that they have entered into agreements to expand and extend their existing global collaboration to discover, develop, and commercialize fully-human therapeutic monoclonal antibodies. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - November 11, 2009 Category: Pharmaceuticals Source Type: news
Pandemic 2009 Influenza Update: US FDA Approves GSK's Pandemic H1N1 VaccineEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
GlaxoSmithKline (GSK) recently announced that the US Food and Drug Administration (FDA) has approved a supplemental biologics license application (sBLA) for its unadjuvanted influenza A (H1N1) pandemic vaccine. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - November 11, 2009 Category: Pharmaceuticals Source Type: news
TRIN Pharma Starts Phase I Clinical Trial Of TRIN 2755 In Solid TumorsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
TRIN Pharma GmbH, specializing in the development of small molecule drugs for tumor treatment, announced today that BfArM, the German regulatory authority, has approved the start of a Phase I clinical trial of TRIN 2755 in solid tumors. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - November 10, 2009 Category: Pharmaceuticals Source Type: news
Homogeneous Fluorescence-Based Assay For Detecting Intracellular Calcium MobilisationEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Amsbio's Screen Quest Calcium Assay kit provides a homogeneous fluorescence-based assay for detecting intracellular calcium mobilisation across a broad spectrum of biological targets. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - November 10, 2009 Category: Pharmaceuticals Source Type: news
Patheon, Inc. Adds Two Key Industry Leaders To Its Pharmaceutical Development Services BusinessEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Patheon, a global provider of drug development and manufacturing services to the international pharmaceutical industry announced recently that it has named William E. Weiser, Ph.D. as group director, Pharmaceutical Development Services (PDS), Analytical Development at the company's Kit Creek laboratory located in Research Triangle Park, N.C. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - November 10, 2009 Category: Pharmaceuticals Source Type: news
